Maquet Cardiovascular filed a patent infringement lawsuit with the U.S. District Court for Massachusetts against Abiomed over the company’s intravascular blood pumps.
Abiomed allegedly became aware of Maquet’s patent No. 9,789,238 for its implantable devices that may be used to “supplement and even fully support” a patient’s blood circulation around Aug. 24, 2016.
But Abiomed continued to directly infringe patent claims 1, 13 and/or 19 in manufacturing and selling its Impella 2.5, 5.0 and CP intravascular blood pumps, Maquet claimed.
The lawsuit seeks judgement against Abiomed for basic, induced, contributory and willful infringement, among other relief actions.